Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
View Older Stories
-
TD Cowen on Exact Sciences (EXAS): 'Guide Looks Conservative With Multiple Upside Drivers'
-
Exact Sciences (EXAS) PT Raised to $86 at TD Cowen
-
Exact Sciences (EXAS) PT Lowered to $82 at TD Cowen
-
TD Cowen Reiterates Buy Rating on Exact Sciences (EXAS)
-
Exact Sciences (EXAS) seeking 25% price hike on Cologuard Plus - TD Cowen
-
TD Cowen Reiterates Buy Rating on Exact Sciences (EXAS)
-
Exact Sciences stock drops as Guardant Health test supported by FDA panel
-
Exact Sciences (EXAS) PT Lowered to $80 at TD Cowen
-
Exact Sciences to Participate in March Investor Conference
-
Cowen Reiterates Outperform Rating on Exact Sciences (EXAS) Following MCED Test Data
-
Exact Sciences to participate in March investor conferences
-
Exact Sciences to participate in March investor conferences
-
Exact Sciences (EXAS) New Deal with Pfizer a 'Win-Win' - Cowen
-
Exact Sciences' (EXAS) Multi-cancer Screening Test Data Seen as Exciting by Analyst at Cowen
-
UPDATE: Exact Sciences (EXAS) Quickly Trades to High
-
Exact Sciences to participate in Cowen Liquid Biopsy Summit
-
Exact Sciences (EXAS) PT Raised to $135 at Cowen After Colorguard Beat
-
Exact Sciences to participate in March investor conferences
-
Exact Sciences (EXAS) PT Trimmed to $130 at Cowen; Named Best 2020 Idea
-
Exact Sciences (EXAS) Management Meetings Imply Upside to Current Estimates - Cowen
-
UPDATE: Exact Sciences (EXAS) PT Raised to Street High $135 at Cowen
-
Exact Sciences (EXAS) PT Raised to $125 at Cowen After NDR
-
Pre-Open Stock Movers 03/06: (ANF) (ZAYO) (AMBA) Higher; (VLRX) (CLDX) (PRMW) Lower (more...)
-
Exact Sciences to participate in March investor conferences
-
Pre-Open Movers 09/05: (PRQR) (COUP) (VRA) Higher; (HSGX) (CAL) (NVUS) Lower (more...)
-
Exact Sciences (EXAS) PT Raised to $100 at Cowen Following Pfizer Deal Deep-Dive
-
Exact Sciences (EXAS) PT Lowered to $65 at Cowen; Buy on Weakness
-
Exact Sciences (EXAS) PT Raised to 'Street High' $85 at Cowen Following Colorguard Survey
-
Exact Sciences to participate in March investor conferences
-
'Flawed' Taiwan Study Causes Drop in Shares of Exact Sciences (EXAS)
-
Exact Sciences (EXAS) Sell-Off 'Overdone' - Cowen
-
Exact Sciences (EXAS): Another Solid Quarter, PT To $60 - Cowen
-
Exact Sciences (EXAS) Prices 7M Share Offering at $35
-
Exact Sciences Announces Pricing of Public Offering of Common Stock
-
Exact Sciences (EXAS): UNH Reverses Policy On Colorguard - Cowen
-
Exact Sciences (EXAS): More Positive After Management Meeting - Cowen
-
Cowen Saw Nothing 'New/Incremental' in Exact Sciences (EXAS) Short Report
-
Exact Sciences (EXAS) PT Raised to $45 at Cowen Following Cologuard Survey
-
Exact Sciences (EXAS) PT Raised to $40 at Cowen; Guides Still Looks 'Very Conservative'
-
Cowen Reiterates Outperform Rating and $30 PT on Exact Sciences (EXAS); 'Cologuard Added to Medicare Advantage Star Ratings'
-
United Healthcare Issues Non-Coverage Decision on Exact Sciences (EXAS) - Cowen
-
Cowen Starts Exact Sciences (EXAS) at Outperform, $30 PT
-
Exact Sciences to participate in March investor conferences
-
Exact Sciences to participate in events, conferences during March
-
UPDATE: Trading Radar for 10/29: Aetna (AET), LinkedIn (LNKD), Baidu (BIDU), ConocoPhillips (COP), MGM Resorts (MGM), Deckers (DECK) Report
-
Notable Analyst Rating Changes 05/30: (MFRM) (OVTI) (AVY) Upgraded; (SOL) (BLOX) (EXAS) Downgraded
-
Notable Analyst Rating Changes 12/20: (LHO) (FLIR) (AWAY) Upgraded; (NOK) (SD) (GBX) Downgraded
-
Unusual 11 Mid-Day Movers 10/29: FMR, MWW, EONC, VVUS, TNAV, CSTR Higher; NR, NUVA, SNBC, EXAS, GRRF Lower
-
Morning Movers 10/29: FMR, VVUS, MWW, CSTR, TNAV, PTEK, AXTI, EL Higher; NUVA, NR, AMAG, VLCM, TNCC, SNBC, EXAS Lower

